TY  - GEN
AU  - Boige,V
AU  - Barbare,J-C
AU  - Rosmorduc,O
TI  - [Use of sorafenib (Nexavar) in the treatment of hepatocellular carcinoma: PRODIGE AFEF recommendations]
SN  - 0399-8320
PY  - 2008///0710
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Benzenesulfonates
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Clinical Protocols
KW  - Contraindications
KW  - Disease-Free Survival
KW  - Humans
KW  - Liver Neoplasms
KW  - Neoadjuvant Therapy
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Palliative Care
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Pyridines
KW  - Randomized Controlled Trials as Topic
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - antagonists & inhibitors
KW  - Remission Induction
KW  - Sorafenib
KW  - Survival Rate
KW  - raf Kinases
N1  - Publication Type: Journal Article; Practice Guideline
UR  - https://doi.org/10.1016/j.gcb.2007.11.001
ER  -